J&J reportedly settles 7,500 hip-replacement lawsuits for $4B

Johnson & Johnson ($JNJ) has reportedly wrapped up thousands of lawsuits over faulty hip-replacement products with a hefty $4 billion settlement. According to Bloomberg, the deal would resolve more than 7,500 lawsuits, allocating an average of $300,000 to plaintiffs injured by failing implants. Report

Suggested Articles

Amid Amgen's pricing war with Sanofi and Regeneron's Praluent, PCSK9 cholesterol fighter Repatha has shown a clinical benefit for HIV patients.

A month after the FDA approved it, Esperion's Nexletol showed it can lower cholesterol regardless of statin and ezitimibe treatment.

AstraZeneca's Farxiga can help prevent worsening or death in heart failure patients regardless of other therapies received, according to new data.